Lisanti Capital Growth LLC Invests $5.62 Million in Inspire Medical Systems, Inc. (NYSE:INSP)

Lisanti Capital Growth LLC acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 26,615 shares of the company's stock, valued at approximately $5,617,000. Inspire Medical Systems makes up 1.4% of Lisanti Capital Growth LLC's portfolio, making the stock its 17th largest position. Lisanti Capital Growth LLC owned about 0.09% of Inspire Medical Systems as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently made changes to their positions in the business. BNP Paribas Financial Markets grew its holdings in Inspire Medical Systems by 89.4% during the 1st quarter. BNP Paribas Financial Markets now owns 2,297 shares of the company's stock valued at $493,000 after purchasing an additional 1,084 shares during the last quarter. Janney Montgomery Scott LLC raised its holdings in shares of Inspire Medical Systems by 32.8% in the first quarter. Janney Montgomery Scott LLC now owns 1,532 shares of the company's stock valued at $329,000 after acquiring an additional 378 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Inspire Medical Systems by 9.5% in the 1st quarter. SG Americas Securities LLC now owns 2,907 shares of the company's stock worth $624,000 after purchasing an additional 251 shares during the period. Illinois Municipal Retirement Fund boosted its position in Inspire Medical Systems by 61.1% during the 1st quarter. Illinois Municipal Retirement Fund now owns 3,639 shares of the company's stock valued at $782,000 after acquiring an additional 1,380 shares in the last quarter. Finally, Swiss National Bank raised its stake in shares of Inspire Medical Systems by 0.9% during the 1st quarter. Swiss National Bank now owns 58,300 shares of the company's stock worth $12,522,000 after acquiring an additional 500 shares in the last quarter. Institutional investors own 94.91% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Leerink Partners raised their price objective on Inspire Medical Systems from $167.00 to $197.00 and gave the stock a "market perform" rating in a research note on Tuesday, September 10th. Piper Sandler restated an "overweight" rating and set a $260.00 price objective (up from $255.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Truist Financial reaffirmed a "buy" rating and issued a $240.00 price target (up from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. KeyCorp dropped their target price on shares of Inspire Medical Systems from $278.00 to $236.00 and set an "overweight" rating for the company in a report on Wednesday, August 7th. Finally, Royal Bank of Canada reissued an "outperform" rating and issued a $260.00 price target on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $227.75.

Inspire Medical Systems Stock Up 2.1 %

Inspire Medical Systems stock traded up $4.22 during trading on Monday, reaching $200.84. The stock had a trading volume of 400,080 shares, compared to its average volume of 599,694. The business has a 50 day moving average price of $202.62 and a 200 day moving average price of $179.12. The stock has a market cap of $6.02 billion, a PE ratio of 183.76 and a beta of 1.36. Inspire Medical Systems, Inc. has a 52-week low of $123.00 and a 52-week high of $257.40.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The firm had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same quarter last year, the company posted ($0.29) earnings per share. The business's revenue was up 32.6% on a year-over-year basis. On average, equities analysts predict that Inspire Medical Systems, Inc. will post 1.33 EPS for the current fiscal year.

Insider Transactions at Inspire Medical Systems

In other news, insider Randy Ban sold 4,861 shares of the company's stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $188.55, for a total value of $916,541.55. Following the completion of the sale, the insider now owns 3,056 shares of the company's stock, valued at $576,208.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Shawn Mccormick sold 800 shares of Inspire Medical Systems stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $220.00, for a total value of $176,000.00. Following the sale, the director now directly owns 23,140 shares in the company, valued at $5,090,800. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Randy Ban sold 4,861 shares of the firm's stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $188.55, for a total transaction of $916,541.55. Following the transaction, the insider now owns 3,056 shares in the company, valued at $576,208.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,692 shares of company stock worth $1,099,207 over the last ninety days. 4.10% of the stock is currently owned by corporate insiders.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.